NO870448L - Fremgangsmaater og apparat for overvaaking av kardiovaskulaer regulering ved hjelp av spektrumanalyse av hjertets slag. - Google Patents

Fremgangsmaater og apparat for overvaaking av kardiovaskulaer regulering ved hjelp av spektrumanalyse av hjertets slag. Download PDF

Info

Publication number: NO870448L
Authority: NO; Norway
Prior art keywords: heart; fluctuations; heart rhythm; spectrum; heartbeat
Prior art date: 1985-06-05

Application number

NO870448A

Other languages

English (en)

Norwegian (no)

Other versions

NO870448D0 (no

Inventor

Makoto R Arai

Laura E Mcalpine

David Gordon

Original Assignee

Univ Illinois

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-05

Filing date

1987-02-04

Publication date

1987-04-03

1987-02-04 Application filed by Univ Illinois filed Critical Univ Illinois

1987-02-04 Publication of NO870448D0 publication Critical patent/NO870448D0/no

1987-04-03 Publication of NO870448L publication Critical patent/NO870448L/no

Links

230000002526 effect on cardiovascular system Effects 0.000 title claims description 38
238000000034 method Methods 0.000 title claims description 31
238000010183 spectrum analysis Methods 0.000 title claims description 19
238000012544 monitoring process Methods 0.000 title claims description 13
230000033228 biological regulation Effects 0.000 title description 9
238000001228 spectrum Methods 0.000 claims description 66
230000033764 rhythmic process Effects 0.000 claims description 56
230000000694 effects Effects 0.000 claims description 32
210000000056 organ Anatomy 0.000 claims description 28
230000004217 heart function Effects 0.000 claims description 26
230000036391 respiratory frequency Effects 0.000 claims description 15
230000006870 function Effects 0.000 claims description 14
238000006243 chemical reaction Methods 0.000 claims description 7
230000035876 healing Effects 0.000 claims description 6
230000036387 respiratory rate Effects 0.000 claims description 5
230000005540 biological transmission Effects 0.000 claims description 2
230000004064 dysfunction Effects 0.000 claims 4
238000006467 substitution reaction Methods 0.000 claims 2
239000000872 buffer Substances 0.000 description 51
239000003990 capacitor Substances 0.000 description 39
230000000875 corresponding effect Effects 0.000 description 22
230000000241 respiratory effect Effects 0.000 description 19
230000003595 spectral effect Effects 0.000 description 14
206010019280 Heart failures Diseases 0.000 description 12
238000010586 diagram Methods 0.000 description 10
206010003671 Atrioventricular Block Diseases 0.000 description 9
208000010271 Heart Block Diseases 0.000 description 9
208000028399 Critical Illness Diseases 0.000 description 8
238000004458 analytical method Methods 0.000 description 8
230000000747 cardiac effect Effects 0.000 description 8
238000012360 testing method Methods 0.000 description 8
230000001734 parasympathetic effect Effects 0.000 description 7
210000001774 pressoreceptor Anatomy 0.000 description 7
230000009467 reduction Effects 0.000 description 7
230000001105 regulatory effect Effects 0.000 description 7
230000002889 sympathetic effect Effects 0.000 description 7
208000032843 Hemorrhage Diseases 0.000 description 6
230000036772 blood pressure Effects 0.000 description 6
230000008859 change Effects 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
230000006872 improvement Effects 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
230000011514 reflex Effects 0.000 description 6
230000004044 response Effects 0.000 description 6
238000005070 sampling Methods 0.000 description 6
238000001356 surgical procedure Methods 0.000 description 6
206010007559 Cardiac failure congestive Diseases 0.000 description 5
102100040862 Dual specificity protein kinase CLK1 Human genes 0.000 description 5
208000001953 Hypotension Diseases 0.000 description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
108091008698 baroreceptors Proteins 0.000 description 5
230000000740 bleeding effect Effects 0.000 description 5
238000007600 charging Methods 0.000 description 5
239000012530 fluid Substances 0.000 description 5
238000005259 measurement Methods 0.000 description 5
239000001301 oxygen Substances 0.000 description 5
229910052760 oxygen Inorganic materials 0.000 description 5
230000029058 respiratory gaseous exchange Effects 0.000 description 5
238000012546 transfer Methods 0.000 description 5
239000003814 drug Substances 0.000 description 4
229940079593 drug Drugs 0.000 description 4
210000001002 parasympathetic nervous system Anatomy 0.000 description 4
230000002093 peripheral effect Effects 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
102100040844 Dual specificity protein kinase CLK2 Human genes 0.000 description 3
101000749294 Homo sapiens Dual specificity protein kinase CLK1 Proteins 0.000 description 3
101000749291 Homo sapiens Dual specificity protein kinase CLK2 Proteins 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
230000004872 arterial blood pressure Effects 0.000 description 3
210000003403 autonomic nervous system Anatomy 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004204 blood vessel Anatomy 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
230000009084 cardiovascular function Effects 0.000 description 3
230000001447 compensatory effect Effects 0.000 description 3
208000028831 congenital heart disease Diseases 0.000 description 3
238000013480 data collection Methods 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000011161 development Methods 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
238000007599 discharging Methods 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
238000001914 filtration Methods 0.000 description 3
208000019622 heart disease Diseases 0.000 description 3
230000000004 hemodynamic effect Effects 0.000 description 3
230000036543 hypotension Effects 0.000 description 3
230000001404 mediated effect Effects 0.000 description 3
230000002107 myocardial effect Effects 0.000 description 3
230000036454 renin-angiotensin system Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
230000035939 shock Effects 0.000 description 3
239000003071 vasodilator agent Substances 0.000 description 3
230000001457 vasomotor Effects 0.000 description 3
238000009423 ventilation Methods 0.000 description 3
208000006179 Aortic Coarctation Diseases 0.000 description 2
208000006017 Cardiac Tamponade Diseases 0.000 description 2
206010009807 Coarctation of the aorta Diseases 0.000 description 2
208000010496 Heart Arrest Diseases 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
230000003444 anaesthetic effect Effects 0.000 description 2
208000007502 anemia Diseases 0.000 description 2
210000000709 aorta Anatomy 0.000 description 2
102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
208000034158 bleeding Diseases 0.000 description 2
238000004422 calculation algorithm Methods 0.000 description 2
YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
238000004891 communication Methods 0.000 description 2
238000012937 correction Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000007667 floating Methods 0.000 description 2
230000036541 health Effects 0.000 description 2
230000001121 heart beat frequency Effects 0.000 description 2
230000013632 homeostatic process Effects 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
208000021822 hypotensive Diseases 0.000 description 2
230000001077 hypotensive effect Effects 0.000 description 2
230000002631 hypothermal effect Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000000297 inotrophic effect Effects 0.000 description 2
238000011835 investigation Methods 0.000 description 2
230000008338 local blood flow Effects 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
238000005399 mechanical ventilation Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000010355 oscillation Effects 0.000 description 2
230000010412 perfusion Effects 0.000 description 2
238000004393 prognosis Methods 0.000 description 2
210000001147 pulmonary artery Anatomy 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
210000000115 thoracic cavity Anatomy 0.000 description 2
230000002861 ventricular Effects 0.000 description 2
239000005541 ACE inhibitor Substances 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
102000005862 Angiotensin II Human genes 0.000 description 1
101800000733 Angiotensin-2 Proteins 0.000 description 1
206010005746 Blood pressure fluctuation Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
206010015856 Extrasystoles Diseases 0.000 description 1
206010018985 Haemorrhage intracranial Diseases 0.000 description 1
206010020591 Hypercapnia Diseases 0.000 description 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
206010022773 Intracranial pressure increased Diseases 0.000 description 1
206010022840 Intraventricular haemorrhage Diseases 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
241000282341 Mustela putorius furo Species 0.000 description 1
208000009525 Myocarditis Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
208000004880 Polyuria Diseases 0.000 description 1
208000035965 Postoperative Complications Diseases 0.000 description 1
208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
101100328360 Schizosaccharomyces pombe (strain 972 / ATCC 24843) clr1 gene Proteins 0.000 description 1
206010049418 Sudden Cardiac Death Diseases 0.000 description 1
238000010162 Tukey test Methods 0.000 description 1
206010047281 Ventricular arrhythmia Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
229950006323 angiotensin ii Drugs 0.000 description 1
230000002567 autonomic effect Effects 0.000 description 1
230000035559 beat frequency Effects 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000035565 breathing frequency Effects 0.000 description 1
229940124630 bronchodilator Drugs 0.000 description 1
229940127214 bronchodilator medication Drugs 0.000 description 1
230000008822 capillary blood flow Effects 0.000 description 1
238000007675 cardiac surgery Methods 0.000 description 1
230000002612 cardiopulmonary effect Effects 0.000 description 1
150000003943 catecholamines Chemical class 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000010219 correlation analysis Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
238000009795 derivation Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
201000011304 dilated cardiomyopathy 1A Diseases 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000035619 diuresis Effects 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
230000001882 diuretic effect Effects 0.000 description 1
238000005553 drilling Methods 0.000 description 1
238000004870 electrical engineering Methods 0.000 description 1
208000016253 exhaustion Diseases 0.000 description 1
230000002169 extracardiac Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000009499 grossing Methods 0.000 description 1
230000010247 heart contraction Effects 0.000 description 1
210000005003 heart tissue Anatomy 0.000 description 1
230000002489 hematologic effect Effects 0.000 description 1
239000005555 hypertensive agent Substances 0.000 description 1
230000000870 hyperventilation Effects 0.000 description 1
208000000122 hyperventilation Diseases 0.000 description 1
208000018875 hypoxemia Diseases 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
210000005246 left atrium Anatomy 0.000 description 1
208000018773 low birth weight Diseases 0.000 description 1
231100000533 low birth weight Toxicity 0.000 description 1
238000007726 management method Methods 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910044991 metal oxide Inorganic materials 0.000 description 1
150000004706 metal oxides Chemical class 0.000 description 1
208000019266 moderate heart failure Diseases 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
238000006213 oxygenation reaction Methods 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
230000036513 peripheral conductance Effects 0.000 description 1
230000036581 peripheral resistance Effects 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
230000001144 postural effect Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
210000005245 right atrium Anatomy 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
210000002820 sympathetic nervous system Anatomy 0.000 description 1
230000028016 temperature homeostasis Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000001331 thermoregulatory effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000002792 vascular Effects 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
230000003519 ventilatory effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Physiology (AREA)
Biophysics (AREA)
Pathology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Medical Informatics (AREA)
Public Health (AREA)
Surgery (AREA)
Animal Behavior & Ethology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Signal Processing (AREA)
Child & Adolescent Psychology (AREA)
Developmental Disabilities (AREA)
Hospice & Palliative Care (AREA)
Computer Vision & Pattern Recognition (AREA)
Social Psychology (AREA)
Artificial Intelligence (AREA)
Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Apparatus For Radiation Diagnosis (AREA)
Ultra Sonic Daignosis Equipment (AREA)

NO870448A 1985-06-05 1987-02-04 Fremgangsmaater og apparat for overvaaking av kardiovaskulaer regulering ved hjelp av spektrumanalyse av hjertets slag. NO870448L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US74208885A	1985-06-05	1985-06-05
PCT/US1986/001193 WO1986007248A1 (en)	1985-06-05	1986-05-30	Methods and apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis

Publications (2)

Publication Number	Publication Date
NO870448D0 NO870448D0 (no)	1987-02-04
NO870448L true NO870448L (no)	1987-04-03

Family

ID=24983432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO870448A NO870448L (no)	1985-06-05	1987-02-04	Fremgangsmaater og apparat for overvaaking av kardiovaskulaer regulering ved hjelp av spektrumanalyse av hjertets slag.

Country Status (15)

Country	Link
EP (1)	EP0223846A4 (da)
JP (1)	JPS63500153A (da)
KR (1)	KR870700317A (da)
CN (1)	CN86104798A (da)
AU (1)	AU5965486A (da)
BR (1)	BR8606714A (da)
CA (1)	CA1257395A (da)
DK (1)	DK55787A (da)
ES (1)	ES8707853A1 (da)
FI (1)	FI870470A0 (da)
GR (1)	GR861453B (da)
IL (1)	IL78931A0 (da)
NO (1)	NO870448L (da)
WO (1)	WO1986007248A1 (da)
ZA (1)	ZA864119B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6002952A (en)	1997-04-14	1999-12-14	Masimo Corporation	Signal processing apparatus and method
US6600949B1 (en)	1999-11-10	2003-07-29	Pacesetter, Inc.	Method for monitoring heart failure via respiratory patterns
EP1146433A1 (en) *	2000-04-14	2001-10-17	Novacor	Method and apparatus for detecting sleep disorders using the variability of the RR interval in an ECG waveform
US6589188B1 (en)	2000-05-05	2003-07-08	Pacesetter, Inc.	Method for monitoring heart failure via respiratory patterns
US6741885B1 (en)	2000-12-07	2004-05-25	Pacesetter, Inc.	Implantable cardiac device for managing the progression of heart disease and method
JP4788915B2 (ja)	2004-03-24	2011-10-05	日本光電工業株式会社	電極を有する生体情報計測用衣服および生体情報計測システム
EP1884189A1 (en) *	2006-08-03	2008-02-06	Pulsion Medical Systems AG	Apparatus and method for determining a physiologic parameter of a patient applying fourier transformation
JP5167156B2 (ja) *	2009-01-19	2013-03-21	株式会社デンソー	生体状態評価装置、生体状態評価システム、プログラム、及び記録媒体
SG11201400446WA (en) *	2011-09-08	2014-09-26	Apn Health Llc	Automatically determining 3d catheter location and orientation using 2d fluoroscopy only
US10433740B2 (en)	2012-09-12	2019-10-08	Heartflow, Inc.	Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US10398386B2 (en) *	2012-09-12	2019-09-03	Heartflow, Inc.	Systems and methods for estimating blood flow characteristics from vessel geometry and physiology
CN108853726B (zh) *	2018-05-09	2023-10-24	中国计量大学	电针治疗仪专用校准系统及方法
CN113768515A (zh) *	2021-09-17	2021-12-10	重庆邮电大学	一种基于深度卷积神经网络的心电信号分类方法
CN113951846B (zh) *	2021-12-17	2022-04-12	北京麦邦光电仪器有限公司	脉搏波信号处理方法、装置及可读存储介质
CN118175452B (zh) *	2024-03-13	2024-09-24	深圳市麦驰信息技术有限公司	自动告警的医护对讲系统、方法、计算设备和存储介质

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2527475C3 (de) *	1975-06-20	1978-12-07	Hellige Gmbh, 7800 Freiburg	Gerät zur automatischen Überwachung von Körperfunktionen
US4422458A (en) *	1980-04-28	1983-12-27	Montefiore Hospital And Medical Center, Inc.	Method and apparatus for detecting respiratory distress
US4342318A (en) *	1980-08-25	1982-08-03	Medtronic, Inc.	Physiological waveform processor
US4379460A (en) *	1980-09-18	1983-04-12	Judell Neil H K	Method and apparatus for removing cardiac artifact in impedance plethysmographic respiration monitoring
US4463764A (en) *	1981-09-29	1984-08-07	Medical Graphics Corporation	Cardiopulmonary exercise system
US4506678A (en) *	1982-06-07	1985-03-26	Healthdyne, Inc.	Patient monitor for providing respiration and electrocardiogram signals
US4519395A (en) *	1982-12-15	1985-05-28	Hrushesky William J M	Medical instrument for noninvasive measurement of cardiovascular characteristics

1986
- 1986-05-27 IL IL78931A patent/IL78931A0/xx unknown
- 1986-05-30 EP EP19860903945 patent/EP0223846A4/en not_active Withdrawn
- 1986-05-30 AU AU59654/86A patent/AU5965486A/en not_active Abandoned
- 1986-05-30 BR BR8606714A patent/BR8606714A/pt unknown
- 1986-05-30 JP JP61503324A patent/JPS63500153A/ja active Pending
- 1986-05-30 WO PCT/US1986/001193 patent/WO1986007248A1/en not_active Ceased
- 1986-06-03 ZA ZA864119A patent/ZA864119B/xx unknown
- 1986-06-03 ES ES555655A patent/ES8707853A1/es not_active Expired
- 1986-06-04 GR GR861453A patent/GR861453B/el unknown
- 1986-06-04 CN CN198686104798A patent/CN86104798A/zh active Pending
- 1986-06-04 CA CA000510803A patent/CA1257395A/en not_active Expired
1987
- 1987-02-03 DK DK055787A patent/DK55787A/da not_active Application Discontinuation
- 1987-02-04 NO NO870448A patent/NO870448L/no unknown
- 1987-02-04 FI FI870470A patent/FI870470A0/fi not_active Application Discontinuation
- 1987-02-05 KR KR870700101A patent/KR870700317A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
IL78931A0 (en)	1986-09-30
FI870470A7 (fi)	1987-02-04
BR8606714A (pt)	1987-08-11
EP0223846A4 (en)	1987-10-19
ES8707853A1 (es)	1987-09-01
CA1257395A (en)	1989-07-11
GR861453B (en)	1986-10-02
JPS63500153A (ja)	1988-01-21
NO870448D0 (no)	1987-02-04
KR870700317A (ko)	1987-12-28
ZA864119B (en)	1987-02-25
AU5965486A (en)	1987-01-07
DK55787A (da)	1987-03-24
CN86104798A (zh)	1987-05-20
EP0223846A1 (en)	1987-06-03
DK55787D0 (da)	1987-02-03
ES555655A0 (es)	1987-09-01
FI870470A0 (fi)	1987-02-04
WO1986007248A1 (en)	1986-12-18

Publication	Publication Date	Title
US4862361A (en)	1989-08-29	Methods and apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis
US4832038A (en)	1989-05-23	Apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis
US7079888B2 (en)	2006-07-18	Method and apparatus for monitoring the autonomic nervous system using non-stationary spectral analysis of heart rate and respiratory activity
Windmann et al.	1999	Dissociating beliefs about heart rates and actual heart rates in patients with cardiac pacemakers
CA1196102A (en)	1985-10-29	Medical instrument for noninvasive measurement of cardiovascular characteristics
WO2002087435A1 (en)	2002-11-07	Device, method and system for monitoring pressure in body cavities
AU2002251604A1 (en)	2003-04-17	Device, method and system for monitoring pressure in body cavities
Van Montfrans et al.	1987	Accuracy of auscultatory blood pressure measurement with a long cuff.
Begic et al.	2016	The use of continuous electrocardiographic holter monitoring in pediatric cardiology
CA1257395A (en)	1989-07-11	Methods and apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis
Shortland et al.	1988	Blood pressure measurements in very low birth weight infants over the first week of life
Lacko et al.	2018	Severe acute heart failure-experimental model with very low mortality
Larsen et al.	1941	The normal electrocardiogram: I. Analysis of the extremity derivations from 100 normal persons whose ages ranged from 30 to 50 years
Spodick et al.	1969	Detection of Cardiac Abnormality by Clinical Measurement of Left Ventricular Ejection Time: A Prospective Study of 200 Unselected Patients
Govindan et al.	2007	Early maturation of sinus rhythm dynamics in high-risk fetuses
RU174590U1 (ru)	2017-10-23	Монитор многофункциональный компьютеризированный
Peng et al.	2005	Fractals in physiological control: from heart beat to gait
Shirole et al.	2017	Cardiac autonomous function assessment in congestive heart failure using HRV analysis
Gilsdorf et al.	1973	Posterior hypothalamic effect on gastrointestinal blood flow in the conscious cat
RU2738862C2 (ru)	2020-12-17	Способ диагностики состояния сердечно-сосудистой системы с помощью аппаратно-программного комплекса
Shaikh et al.	2025	Pulse Pattern Variability Analysis in Hypertension and Chronic Liver Diseases
Field et al.	1976	Limitations in the use of the pulmonary capillary
Price et al.	1993	Attempts to continuously monitor autoregulation and compensatory reserve in severe head injuries
Hathaway et al.	2000	Posttransplant improvement in heart rate variability correlates with improved quality of life
CN119214612A (zh)	2024-12-31	一种病位定位系统、方法、终端及存储介质